Tan Yi, Chen Shaotao, Gao Tianjiao, Wang Sixian, Zhou Xinfeng, Liu Mingjun
Departments of Acupuncture and Massage, Changchun University of Chinese Medicine, Changchun, Jilin, China.
Office of Scientific Research, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China.
Front Endocrinol (Lausanne). 2024 Dec 9;15:1443798. doi: 10.3389/fendo.2024.1443798. eCollection 2024.
Diabetes has emerged as the foremost public health challenge of the 21st century, with a notable shift towards managing it through an inflammatory lens. This study seeks to investigate the role of NLRP3 infalmmasome in diabetes over the past ten years, leveraging bibliometric analysis to pinpoint prevailing trends, underscore critical focal points, and establish a roadmap for subsequent research endeavors.
A literature search was conducted based on the SCI-E database, and all recorded results were downloaded in plain text format for subsequent analysis. The analysis was carried out using Vosviewer1.6.18, citespace6.3R1, and Microsoft Excel 2021 software, focusing on the following terms: country, institution, author, journal, references, and keywords.
From January 1, 2014, to December 31, 2023, a total of 1373 articles were retrieved, with China, the United States, and Italy contributing the majority of records. Harbin Medical University, Nanjing Medical University, and Central South University stand as the top three most productive institutions. "International Journal of Molecular Sciences" leads the way with the highest number of publications, closely followed by "Frontiers in Immunology" and "Frontiers in Pharmacology." Authors Wang Wei boast the most publications, closely followed by Li Xiang and Wang Yan. Within the superimposed keyword network, four primary clusters emerge: (1) exploring the link between NLRP3 infalmmasome and inflammatory diseases like diabetes; (2) investigating the cellular-level pathogenesis of diabetes-related conditions; (3) examining diabetes characteristics and associated suppression techniques; (4) studying cell morphology alterations, including pyroptosis. Over the past five years, key topics in this field have revolved around the "heart", "damage", "caspase 1 activation", "NLRP3", and "diabetic kidney disease".
This paper has identified the hot spots and trends concerning the role of NLRP3 infalmmasome in diabetes, thereby providing a valuable reference for future research. Furthermore, it is anticipated that pyroptosis and diabetes-related diseases will become frontier research topics that may garner significant attention in the coming years.
糖尿病已成为21世纪首要的公共卫生挑战,在管理方式上正显著转向从炎症角度进行干预。本研究旨在通过文献计量分析,探究过去十年中NLRP3炎性小体在糖尿病研究中的作用,以明确主要趋势、突出关键重点,并为后续研究工作制定路线图。
基于SCI-E数据库进行文献检索,所有记录结果均以纯文本格式下载以供后续分析。使用Vosviewer1.6.18、CiteSpace6.3R1和Microsoft Excel 2021软件进行分析,重点关注以下方面:国家、机构、作者、期刊、参考文献和关键词。
在2014年1月1日至2023年12月31日期间,共检索到1373篇文章,其中中国、美国和意大利贡献了大部分记录。哈尔滨医科大学、南京医科大学和中南大学是发文量最高的前三所机构。《国际分子科学杂志》发表文章数量最多,紧随其后的是《免疫学前沿》和《药理学前沿》。作者王伟发表的文章最多,其次是李祥和王燕。在叠加关键词网络中,出现了四个主要聚类:(1)探索NLRP3炎性小体与糖尿病等炎症性疾病之间的联系;(2)研究糖尿病相关病症的细胞水平发病机制;(3)研究糖尿病特征及相关抑制技术;(4)研究包括细胞焦亡在内的细胞形态改变。在过去五年中,该领域的关键主题围绕“心脏”“损伤”“半胱天冬酶1激活”“NLRP3”和“糖尿病肾病”展开。
本文确定了NLRP3炎性小体在糖尿病研究中作用的热点和趋势,从而为未来研究提供了有价值的参考。此外,预计细胞焦亡和糖尿病相关疾病将成为未来几年可能备受关注的前沿研究课题。